Relevant bibliographies by topics / LMP7

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'LMP7'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'LMP7.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "LMP7"

1

Jamaluddin, Mohammad, Shaofei Wang, Roberto P. Garofalo та ін. "IFN-β mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 280, № 2 (2001): L248—L257. http://dx.doi.org/10.1152/ajplung.2001.280.2.l248.

Full text
Abstract:
Major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes (CTLs) clear respiratory tract infections caused by the pneumovirus respiratory syncytial virus (RSV) and also mediate vaccine-induced pulmonary injury. Herein we examined the mechanism for RSV-induced MHC class I presentation. Like infectious viruses, conditioned medium from RSV-infected cells (RSV-CM) induces naive cells to coordinately express a gene cluster encoding the transporter associated with antigen presentation 1 (TAP1) and low molecular mass protein (LMP) 2 and LMP7. Neutralization of RSV-CM with anti
APA, Harvard, Vancouver, ISO, and other styles
2

Griffin, Thomas A., Dipankar Nandi, Miguel Cruz та ін. "Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits". Journal of Experimental Medicine 187, № 1 (1998): 97–104. http://dx.doi.org/10.1084/jem.187.1.97.

Full text
Abstract:
LMP2, LMP7, and MECL are interferon γ–inducible catalytic subunits of vertebrate 20S proteasomes, which can replace constitutive catalytic subunits (delta, X, and Z, respectively) during proteasome biogenesis. We demonstrate that MECL requires LMP2 for efficient incorporation into preproteasomes, and preproteasomes containing LMP2 and MECL require LMP7 for efficient maturation. The latter effect depends on the presequence of LMP7, but not on LMP7 catalytic activity. This cooperative mechanism favors the assembly of homogeneous “immunoproteasomes” containing all three inducible subunits, sugges
APA, Harvard, Vancouver, ISO, and other styles
3

Sijts, Alice J. A. M., Thomas Ruppert, Barbara Rehermann, Marion Schmidt, Ulrich Koszinowski, and Peter-M. Kloetzel. "Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes." Journal of Experimental Medicine 191, no. 3 (2000): 503–14. http://dx.doi.org/10.1084/jem.191.3.503.

Full text
Abstract:
Interferon (IFN)-γ–induced cells express the proteasome subunits low molecular weight protein (LMP)2, LMP7, and MECL-1 (multicatalytic endopeptidase complex–like 1), leading to the formation of immunoproteasomes. Although these subunits are thought to optimize MHC class I antigen processing, the extent of their role and the mechanistic aspects involved remain unclear. Herein, we study the proteolytic generation of an human histocompatibility leukocyte antigen (HLA)-Aw68–restricted hepatitis B virus core antigen (HBcAg) cytotoxic T lymphocyte (CTL) epitope that is recognized by peripheral blood
APA, Harvard, Vancouver, ISO, and other styles
4

Nelson, Judith E., Claudia Altschuller-Felberg, Anna Loukissa, and Christopher Cardozo. "Proteasome from cytokine-treated human cells shows stimulated BrAAP activity and depressed PGPH activity." Biochemistry and Cell Biology 78, no. 2 (2000): 115–18. http://dx.doi.org/10.1139/o00-006.

Full text
Abstract:
The branched chain amino acid-preferring (BrAAP) activity of multicatalytic proteinase complex isolated from human umbilical vein endothelial cells and treated with interferon-gamma was increased more than 2-fold, which was associated with a marked increase in LMP7 expression and decreased peptidylglutamyl peptide-hydrolyzing activity. Increases in BrAAP activity in supernatants from cells treated with interferon-gamma, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, or lipopolysaccharide paralleled the increases in LMP7 expression. These findings are consistent with the conclus
APA, Harvard, Vancouver, ISO, and other styles
5

Hisamatsu, H., N. Shimbara, Y. Saito, et al. "Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma." Journal of Experimental Medicine 183, no. 4 (1996): 1807–16. http://dx.doi.org/10.1084/jem.183.4.1807.

Full text
Abstract:
Interferon (IFN) gamma induces replacements of the proteasomal subunits X and Y by LMP7 and LMP2, respectively, resulting in an alteration of the proteolytic specificity. We found a third pair of proteasome subunits expressed reciprocally in response to IFN-gamma. Molecular cloning of a cDNA encoding one subunit designated as Z, downregulated by IFN-gamma, showed that it is a novel proteasomal subunit with high homology to MECL1, which is markedly induced by IFN-gamma. Thus, IFN-gamma induces subunit replacements of not only X and Y by LMP7 and LMP2, respectively, but also of Z by MECL1, produ
APA, Harvard, Vancouver, ISO, and other styles
6

Parlati, Francesco, Monette Aujay, Siv Lise Bedringaas, et al. "Anti-Tumor Activity of Immunoproteasome Selective Inhibitors." Blood 110, no. 11 (2007): 1599. http://dx.doi.org/10.1182/blood.v110.11.1599.1599.

Full text
Abstract:
Abstract Background: The immunoproteasome is a form of the proteasome that is distinct from the broadly expressed constitutive proteasome. The immunoproteasome, which is predominant in hematopoetic cells, contains the unique active site subunits, LMP7, LMP2 and MECL1, accounting for the chymotrypsin-like, caspase-like and trypsin-like activity respectively. The proteasome inhibitors bortezomib and carfilzomib have validated the proteasome as a therapeutic target in hematologic malignancies; however these inhibitors target both the constitutive and immunoproteasome. We hypothesized that selecti
APA, Harvard, Vancouver, ISO, and other styles
7

Maksymowych, Walter P., Takashi Ikawa, Akihiro Yamaguchi, et al. "Invasion by Salmonella typhimurium Induces Increased Expression of the LMP, MECL, and PA28 Proteasome Genes and Changes in the Peptide Repertoire of HLA-B27." Infection and Immunity 66, no. 10 (1998): 4624–32. http://dx.doi.org/10.1128/iai.66.10.4624-4632.1998.

Full text
Abstract:
ABSTRACT We have analyzed proteasomal adaptation and associated changes in the B27-bound peptide repertoire in response to cellular invasion withSalmonella. The peptide repertoire of HLA-B27 complexes was analyzed by two different methods: (i) high-pressure liquid chromatography (HPLC) profiles of newly synthesized peptides eluted from B27 following metabolic labeling with arginine and (ii) reactivities with two B27 monoclonal antibodies, Ye-2 and B27.M2, sensitive to peptide-induced conformational changes. LMP, MECL, and PA28 expression was analyzed by reverse transcription-PCR (RT-PCR) of mR
APA, Harvard, Vancouver, ISO, and other styles
8

Tubío Santamaría, Nuria, Jonas Tönsing, Tina M. Schnoeder, et al. "Selective Dependency of MLL-Rearranged Leukemia on Immunoproteasome Function." Blood 134, Supplement_1 (2019): 529. http://dx.doi.org/10.1182/blood-2019-122100.

Full text
Abstract:
Several cellular pathways control the fine balance between self-renewal and differentiation to maintain leukemia-initiating cell (LIC) function. To identify cellular dependencies with relevance for oncogenic fusion proteins, we performed global proteome profiling. Acute myeloid leukemia (AML) was induced by retroviral expression of either MLL-AF9 (MA9) or AML1-ETO9a (AE) in murine hematopoietic stem and progenitor cells (HSPCs) (Lineage-Sca1+Kit+, LSK) which were subsequently transplanted into irradiated syngeneic recipients. After onset of leukemia, LIC-enriched (GFP+ Kithigh) cells isolated
APA, Harvard, Vancouver, ISO, and other styles
9

Dimasuay, Kris Genelyn, Amelia Sanchez, Niccolette Schaefer, Jorge Polanco, Deborah A. Ferrington, and Hong Wei Chu. "Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways." Clinical Science 132, no. 15 (2018): 1711–23. http://dx.doi.org/10.1042/cs20180337.

Full text
Abstract:
Rhinovirus (RV) infection is involved in acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). RV primarily infects upper and lower airway epithelium. Immunoproteasomes (IP) are proteolytic machineries with multiple functions including the regulation of MHC class I antigen processing during viral infection. However, the role of IP in RV infection has not been explored. We sought to investigate the expression and function of IP during airway RV infection. Primary human tracheobronchial epithelial (HTBE) cells were cultured at air–liquid interface (ALI) and treated with
APA, Harvard, Vancouver, ISO, and other styles
10

Niepiekło-Miniewska, Wanda, Łukasz Matusiak, Joanna Narbutt, et al. "Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis." Life 11, no. 4 (2021): 333. http://dx.doi.org/10.3390/life11040333.

Full text
Abstract:
Atopic dermatitis (AD) is a chronic and recurrent inflammatory dermatosis. We recently described an association of the C allele of the single nucleotide polymorphism (SNP) rs26618 in the ERAP1 gene and a synergism of ERAP1 and ERAP2 effects on AD risk. Here, we examined whether polymorphisms of other antigen-presenting machinery genes encoding immunoproteasome components LMP2 and LMP7 and peptide transporter components TAP1 and TAP2 may also affect susceptibility to AD or its outcome. We found that the LMP7 rs2071543*T allele decreased disease risk by about 1.5-fold (odds ratio 0.66, 95% confi
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "LMP7"

1

Säring, Paula [Verfasser]. "Characterization of the immunproteasome subunits LMP2 and LMP7 in the mouse brain / Paula Säring." Magdeburg : Universitätsbibliothek Otto-von-Guericke-Universität, 2019. http://d-nb.info/1219964980/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vachharajani, Niyati [Verfasser], and Alexander [Akademischer Betreuer] Višekruna. "Selective targeting of immunoproteasome subunit LMP7 prevents colitis-associated carcinogenesis / Niyati Vachharajani ; Betreuer: Alexander Višekruna." Marburg : Philipps-Universität Marburg, 2016. http://d-nb.info/1121783376/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dan, Cristian Ioan [Verfasser]. "Einfluss der Defizienz der immunoproteasomalen Untereinheit LMP7 auf die Entwicklung und Progression der Atherosklerose / Cristian Ioan Dan." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2021. http://d-nb.info/1228860386/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pötzsch, Max [Verfasser]. "Charakterisierung der Auswirkungen einer Defizienz der proteasomalen Untereinheit β5/LMP7 auf die Funktion von Monozyten und Makrophagen / Max Pötzsch". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1218078014/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

ARNOLD, DANIELE. "Le controle genetique de la presentation de l'antigene par les molecules de classe i du complexe majeur d'histocompatibilite (cmh). Etude du transporteur de peptides (tap1/tap2) et des sous-unites proteasiques (lmp2/lmp7)." Université Louis Pasteur (Strasbourg) (1971-2008), 1993. http://www.theses.fr/1993STR13141.

Full text
Abstract:
Les molecules de classe i du cmh presentent des peptides d'origine endogene a la surface de la cellule, dans le but d'assurer une surveillance par les cellules t#c#d#8#+. L'assemblage des molecules de classe i est une etape incontournable pour une migration du complexe de classe i vers la surface cellulaire. Ce mecanisme est interrompu si les peptides generes dans le cytoplasme sont incapables de traverser la membrane du reticulum endoplasmique (re), pour s'associer aux chaines de classe i naissantes. Par marche chromosomique et cartographie de deletions chez des mutants d'assemblage, nous avo
APA, Harvard, Vancouver, ISO, and other styles
6

Kalim, Khalid Wasim [Verfasser]. "The role of immunoproteasome subunit LMP7 in modulating T-helper cell differentiation and progression of autoimmune diseases / Khalid Wasim Kalim." Konstanz : Bibliothek der Universität Konstanz, 2013. http://d-nb.info/104650455X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kirschner, Felicia Claudia. "Proteasome subunit deficiency influences the innate immune response to Streptococcus pneumoniae." Doctoral thesis, Humboldt-Universität zu Berlin, Lebenswissenschaftliche Fakultät, 2016. http://dx.doi.org/10.18452/17423.

Full text
Abstract:
Proteasomen, die die proteolytisch aktiven Untereinheiten LMP7, LMP2 und MECL1 inkorporieren, nennt man Immunoproteasomen. Während einer Immunreaktion führen diese regulierende sowie modulierende Funktionenaus. Sie sind konstitutiv exprimiert in Zellen hämatopoetischen Ursprungs, ein Bestandteil des angeborenen Immunsystems, die die erste Angriffsfront gegen pathogene Mikroorganismen ausbilden. Um die Bedeutung des Immunoproteasoms für die angeborene Immunantwort bei einer Streptococcus pneumoniae Infektion auf zu zeigen, charakterisierten wir den Krankheitsverlauf einer bakteriellen Pneumonie
APA, Harvard, Vancouver, ISO, and other styles
8

Goetzke, Carl Christoph [Verfasser]. "Die Bedeutung des Low Molecular Weight Protein 7 (LMP7)- spezifischen Inhibitors ONX 0914 bei der viralen Infektion der Maus / Carl Christoph Goetzke." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2018. http://d-nb.info/1170876463/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Heink, Sylvia. "Die proteasomale Homöostase." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2005. http://dx.doi.org/10.18452/15308.

Full text
Abstract:
Das Proteasom spielt eine zentrale Rolle beim Proteinabbau und der Antigen-Generierung für die adaptive Immunantwort. Vertebraten exprimieren zwei Typen des proteolytischen 20S-Kernkomplexes: das konstitutive c20S (mit den aktiven Untereinheiten beta 1, 2, 5) und das Immunoproteasom i20S (mit den Immunountereinheiten LMP2, MECL-1, LMP7). Die i20S-Expression wird durch Interferon_gamma (IFNg) induziert, was die Antigen-Präsentation auf MHC Klasse I und die Immunantwort gegen infizierte bzw. maligne entartete Zellen durch cytotoxische T-Zellen steigert. Proteasomen werden über komplexe, bisher
APA, Harvard, Vancouver, ISO, and other styles
10

Joeris, Thorsten. "The impact of [beta] 5i-deficiency on structure and function of 20S proteasomes in Listeria monocytogenes infection." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2009. http://dx.doi.org/10.18452/15895.

Full text
Abstract:
Das Proteasomsystem ist die Hauptquelle von Peptiden für die MHC Klasse I Antigen-Präsentation. In Vertebraten kann dieses durch die Expression verschiedener Subtypen des 20S Proteasoms moduliert werden. Die häufigsten Subtypen sind konstitutive Proteasomen (c20S) mit den katalytischen Untereinheiten beta1, beta2 und beta5 und Immunoproteasomen (i20S) mit den Immunountereinheiten beta1i, beta2i und beta5i. Die Expression von i20S optimiert in der Regel die MHC Klasse I Antigen-Präsentation, indem die Bildung von Peptiden mit hoher Affinität zu MHC I Molekülen verstärkt wird. Die Bildung von i2
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "LMP7"

1

Arakelian, Hrant. LMP fundamental theory. Pub. House Sarvard Hrat, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Literary market place: LMP. R.R. Bowker, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Carrasco, Ana Isabel Navarro. Léxico de Estepona: Según datos del ALEA y del LMP. Universidad de Alicante, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

George, Juliet Helen. Studies on the effects of Epstein-Barr virus-encoded latent membrane protein 2 (LMP2) on human epithelial cells. University of Birmingham, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Today, Inc Information. Literary market place: LMP 2010 : the directory of the American book publishing industry with industry yellow pages. 7th ed. Information Today, Inc., 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

LMP 2014: Literary market place : the directory of the American book publishing industry with industry yellow pages. 7th ed. Information Today, Inc., 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Inc, Information Today. LMP, 2006: Literary market place : the directory of the American book publishing industry, with industry yellow pages. Information Today, Inc., 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Glasier, Mary-Ann M. A role for SHP-1 and Vav in the abrogation of B cell receptor signal transduction by latent membrane protein 2 (LMP2). National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Czech Republic) International Conference on Local Mechanical Properties (10th 2013 Kutná Hora. Local mechanical properties X: Selected, peer reviewed papers from the 10th International Conference on Local Mechanical Properties (LMP 2013), November 6-8, 2013, Kutná Hora, Czech Republic. Trans Tech Publications, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

LMP 2002. Information Today, Inc., 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "LMP7"

1

Ayodele, Olubukola, and Lillian L. Siu. "New Drugs for Recurrent or Metastatic Nasopharyngeal Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_23.

Full text
Abstract:
AbstractChemotherapy has been the backbone for the treatment of recurrent or metastatic nasopharyngeal carcinoma (RMNPC), which remains an incurable disease. Currently the most active area of therapeutic investigations in RMNPC is in immunotherapy, especially after the results of five anti-programmed death-1 (anti-PD-1) antibodies, i.e. pembrolizumab, nivolumab, camrelizumab, toripalimab and tislelizumab, have demonstrated monotherapy objective response rates of 21%–43%. Combinations using anti-PD1/L1 antibodies as backbone to evaluate their additivity or synergy with cytotoxic chemotherapy, molecularly targeted agents, or other immuno-oncology compounds are actively being developed. Besides immune checkpoint blockade, additional ways to modulate the host immune system, such as Epstein-Barr virus (EBV)-directed vaccination against viral antigens (such as EBNA1, LMP1, LMP2) with dendritic cells or peptides, adoptive cell transfer of autologous or HLA-matched allogeneic EBV-specific cytotoxic T lymphocytes, CAR or TCR T-cell therapy, personalized cancer vaccines and oncolytic viruses are being explored. Finally, novel molecularly targeted agents that have entered human testing in RMNPC include apatinib and anlotinib (antiangiogenic agents), MAK683 (an embryonic ectoderm development or EED protein inhibitor), among others. This review provides an update of ongoing clinical trials evaluating these new compounds in RMNPC.
APA, Harvard, Vancouver, ISO, and other styles
2

Cen, Osman, and Richard Longnecker. "Latent Membrane Protein 2 (LMP2)." In Epstein Barr Virus Volume 2. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22834-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tsang, S., F. Wang, and E. Kieff. "EBNA-2 Transactivation of LMP1." In Epstein-Barr Virus and Human Disease • 1990. Humana Press, 1991. http://dx.doi.org/10.1007/978-1-4612-0405-3_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yates, John T. "Linear Motion Platform (LMP)." In Experimental Innovations in Surface Science. Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4612-2304-7_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kieser, Arnd, and Kai R. Sterz. "The Latent Membrane Protein 1 (LMP1)." In Epstein Barr Virus Volume 2. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22834-1_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Radičová, Tatiana, and Milan Žalman. "Master Slave LMPM Position Control Using Genetic Algorithms." In Advances in Intelligent Systems and Computing. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-32922-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lao, Thuan Duc, Tuan Hoang Anh Nguyen, Dung Huu Nguyen, and Thuy Huyen Ai Le. "Pattern of EBNA-1, EBNA-2, LMP-1 and LMP-2 in Nasopharyngeal Carcinoma in Vietnamese Patients." In 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6). Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4361-1_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kouko, Gildas, Josée Desharnais, and François Laviolette. "Finite Approximation of LMPs for Exact Verification of Reachability Properties." In Quantitative Evaluation of Systems. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30281-8_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Recio, P. U., P. Rauch, and K. Espinosa. "Link Management Protocol (LMP) Evaluation for SDH/Sonet." In Telecommunications and Networking - ICT 2004. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-540-27824-5_99.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Asija, Divya, K. M. Soni, S. K. Sinha, and Vinod Kumar Yadav. "LMP Difference Approach for Management of Transmission Congestion." In Advances in Power Systems and Energy Management. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4394-9_54.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "LMP7"

1

Cai, Miao-Tian, S. U. Sixt, F. Bonella, et al. "The Expression Of Immunoproteasome Subunit LMP7 In Alveolar Macrophages Is Amplified In Hypersensitivity Pneumonitis." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4522.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Klein, Markus, Michael Busch, Christina Esdar, et al. "Abstract LB-054: Discovery and profiling of M3258, a potent and selective LMP7 inhibitor demonstrating high efficacy in multiple myeloma models." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-lb-054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Klein, Markus, Michael Busch, Christina Esdar, et al. "Abstract LB-054: Discovery and profiling of M3258, a potent and selective LMP7 inhibitor demonstrating high efficacy in multiple myeloma models." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-lb-054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sanderson, Michael, Michael Busch, Christina Esdar, et al. "Abstract DDT02-01: First-time disclosure of M3258: A selective inhibitor of the immunoproteasome subunit LMP7 with potential for improved therapeutic utility in multiple myeloma compared to pan-proteasome inhibitors." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-ddt02-01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sanderson, Michael, Michael Busch, Christina Esdar, et al. "Abstract DDT02-01: First-time disclosure of M3258: A selective inhibitor of the immunoproteasome subunit LMP7 with potential for improved therapeutic utility in multiple myeloma compared to pan-proteasome inhibitors." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-ddt02-01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Banerjee, Srijan, Parnab Saha, Bishaljit Paul, and Chandan Kumar Chanda. "ALLOCATING THE VARIABLE COST OF TRANSMISSION LINES DUE TO ELASTIC LOADS IN A CONGESTED POWER MARKET." In Topics in Intelligent Computing and Industry Design. volkson press, 2020. http://dx.doi.org/10.26480/cic.01.2020.99.102.

Full text
Abstract:
In a competitive power market, the elastic demand for electrical energy transmission is viewed as a prime competitor of generator. Remote generators are needed for transmission to compete with local generators. The value of the transmission is based on the difference of Locational Marginal Price (LMP) of the generators across the network. To maintain the well operation of power market, LMPs which provide the price sensitivity is calculated at every bus. The revenue collected by the transmission owners is a convex quadratic function of the amount of power transmitted. This revenue provides a so
APA, Harvard, Vancouver, ISO, and other styles
7

Huang, Wei, Zhen Huang, Dhaval Miyani, and David Lie. "LMP." In ACSAC '16: 2016 Annual Computer Security Applications Conference. ACM, 2016. http://dx.doi.org/10.1145/2991079.2991089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Samanta, Bidisha, Abir De, Abhijnan Chakraborty, and Niloy Ganguly. "LMPP: A Large Margin Point Process Combining Reinforcement and Competition for Modeling Hashtag Popularity." In Twenty-Sixth International Joint Conference on Artificial Intelligence. International Joint Conferences on Artificial Intelligence Organization, 2017. http://dx.doi.org/10.24963/ijcai.2017/373.

Full text
Abstract:
Predicting the popularity dynamics of Twitter hashtags has a broad spectrum of applications. Existing works have mainly focused on modeling the popularity of individual tweets rather than the popularity of the underlying hashtags. Hence, they do not consider several realistic factors for hashtag popularity. In this paper, we propose Large Margin Point Process (LMPP), a probabilistic framework that integrates hashtag-tweet influence and hashtag-hashtag competitions, the two factors which play important roles in hashtag propagation. Furthermore, while considering the hashtag competitions, LMPP l
APA, Harvard, Vancouver, ISO, and other styles
9

Kornbluth, Richard S., Sachin Gupta, James M. Termini, Elizabeth Guirado, and Geoffrey W. Stone. "Abstract B062: Immune activation by LMP1 CD40 pathway and LMP1-IPS-1 STING pathway activators." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-b062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Baradar, Mohamadreza, and Mohammad R. Hesamzadeh. "Calculating negative LMPs from SOCP-OPF." In 2014 IEEE International Energy Conference (ENERGYCON). IEEE, 2014. http://dx.doi.org/10.1109/energycon.2014.6850615.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "LMP7"

1

Lang, J., ed. Link Management Protocol (LMP). RFC Editor, 2005. http://dx.doi.org/10.17487/rfc4204.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dubuc, M., T. Nadeau, J. Lang, and E. McGinnis. Link Management Protocol (LMP) Management Information Base (MIB). RFC Editor, 2006. http://dx.doi.org/10.17487/rfc4327.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dubuc, M., T. Nadeau, J. Lang, E. McGinnis, and A. Farrel. Link Management Protocol (LMP) Management Information Base (MIB). RFC Editor, 2006. http://dx.doi.org/10.17487/rfc4631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fedyk, D., O. Aboul-Magd, D. Brungard, J. Lang, and D. Papadimitriou. A Transport Network View of the Link Management Protocol (LMP). RFC Editor, 2006. http://dx.doi.org/10.17487/rfc4394.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fredette, A., and J. Lang, eds. Link Management Protocol (LMP) for Dense Wavelength Division Multiplexing (DWDM) Optical Line Systems. RFC Editor, 2005. http://dx.doi.org/10.17487/rfc4209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lang, J., and D. Papadimitriou. Synchronous Optical Network (SONET)/Synchronous Digital Hierarchy (SDH) Encoding for Link Management Protocol (LMP) Test Messages. RFC Editor, 2005. http://dx.doi.org/10.17487/rfc4207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Moe, Wayne, and Amir Afzali. Modernization of Technical Requirements for Licensing of Advanced Non-Light Water Reactors: LMP Lessons Learned, Best Practices, and Frequently Asked Questions. Office of Scientific and Technical Information (OSTI), 2020. http://dx.doi.org/10.2172/1700534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cheng, Genhong. Determining if EBV Infection Contributes to Breast Carcinogenesis: Does LMP-1-Mediated Upregulation of EGFR and Bcl-x Affect Breast Cancer Pathogenesis. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada408770.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'LMP7' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography